Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/09/2014US8906888 Low-calcemic 16,23-diene 25-oxime analogs of 1α,25-dihydroxy vitamin D3
12/09/2014US8906887 C7-fluoro substituted tetracycline compounds
12/09/2014US8906886 Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder
12/09/2014US8906885 Treating cancer with HSP90 inhibitory compounds
12/09/2014US8906884 Method of treating graft-rejection using dextran sulfate
12/09/2014US8906883 Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
12/09/2014US8906882 Lipid conjugates in the treatment of allergic rhinitis
12/09/2014US8906881 Use of chitosans for the treatment of nail inflammatory diseases
12/09/2014US8906880 Nucleoside phosphoramidate prodrugs
12/09/2014US8906879 Combination for the treatment of cancer
12/09/2014US8906878 Myocardial perfusion imaging methods and compositions
12/09/2014US8906869 Effective treatment of ovarian cancer using triciribine and related compounds
12/09/2014US8906868 Aminoglycoside derivatives
12/09/2014US8906867 Production method of solid preparation and the solid preparations produced by the method
12/09/2014US8906858 Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis
12/09/2014US8906855 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
12/09/2014US8906853 [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
12/09/2014US8906852 Inhibitors of protein tyrosine kinase activity
12/09/2014US8906846 Method of treating inflammatory bowel disease by administering a clip-inducing agent
12/09/2014US8906634 Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
12/09/2014US8906604 Store-operated calcium cellular assay
12/09/2014US8906503 Fine particles of crystalline polyol, and method of preparing same
12/09/2014US8906429 Medical cannabis lozenges and compositions thereof
12/09/2014US8906427 Treatment for meibomian gland dysfunction or obstruction
12/09/2014US8906425 Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers
12/09/2014US8906424 Licorice polyphenol preparation
12/09/2014US8906421 Methods of dissolving blood clots and the like
12/09/2014US8906420 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
12/09/2014US8906419 Pharmaceutical composition containing water soluble drug
12/09/2014US8906417 Nanostructures for drug delivery
12/09/2014US8906413 Drug formulations having reduced abuse potential
12/09/2014US8906412 GABA analog prodrug sustained release oral dosage forms
12/09/2014US8906411 Pre-compacted calcium-containing compositions
12/09/2014US8906410 Oral dosage form of 25-hydroxyvitamin D
12/09/2014US8906409 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
12/09/2014US8906406 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
12/09/2014US8906398 Insecticide-containing netlike fabric
12/09/2014US8906397 Permeation enhancers for topical formulations
12/09/2014US8906395 Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved
12/09/2014US8906394 Hyaluronic acid based copolymers
12/09/2014US8906393 Biofilm inhibiting composition
12/09/2014US8906384 Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
12/09/2014US8906374 Combination therapy with CD4 lymphocyte depletion and mTOR inhibitors
12/09/2014US8906373 Use of TNF-alpha inhibitor for treatment of psoriasis
12/09/2014US8906364 Antimicrobial compositions and uses thereof
12/09/2014US8906363 Fusion proteins for the treatment of CNS
12/09/2014US8906360 Light-activated cation channel and uses thereof
12/09/2014US8906357 Treatment of multiple sclerosis with masitinib
12/09/2014US8906355 Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
12/09/2014US8906353 Compositions and methods for achieving sustained therapeutic drug concentrations in a subject
12/09/2014US8905997 Therapeutic particles suitable for parenteral administration and methods of making and using same
12/05/2014DE202014104573U1 Pharmazeutische Zusammensetzung zur Schmerzbehandlung A pharmaceutical composition for the treatment of pain
12/04/2014US20140358125 Small molecule delivery with implantable therapeutic device
12/04/2014US20140357876 Use of icaritin for the preparation of composition for treating cancer
12/04/2014US20140357863 Process for preparation of pure linagliptin
12/04/2014US20140357729 Topical composition containing silicone base
12/04/2014US20140357726 Use of pegylated alcohols for the treatment of actinic keratosis
12/04/2014US20140357724 Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
12/04/2014US20140357723 Tricholine Nasal Formulation and Method of Use
12/04/2014US20140357722 Use of Malononitrilamides in Neuropathic Pain
12/04/2014US20140357719 Methods of using omega-3 fatty acids
12/04/2014US20140357718 Compositions for use in controlling intestinal microflora
12/04/2014US20140357717 Methods of treating hypertriglyceridemia
12/04/2014US20140357716 Composite material for tissue repair
12/04/2014US20140357715 Anorectic agent
12/04/2014US20140357712 Therapeutic compositions
12/04/2014US20140357711 Amooranin Compounds and Analogs Thereof and Related Methods of Use
12/04/2014US20140357710 Treatment of circadian rhythm disorders
12/04/2014US20140357708 Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
12/04/2014US20140357706 Stearate Compounds
12/04/2014US20140357691 Methods of Treating Ocular Diseases Using Derivatives of Lipoic Acid
12/04/2014US20140357689 Method for treating abnormal polyglutamine-mediated disease
12/04/2014US20140357688 Method for inhibiting ezh2 expression in breast cancer cells
12/04/2014US20140357686 Method of treating disease by auricular anesthesia of cranial nerves
12/04/2014US20140357683 Methods of treatment and compositions with xanthine oxidase inhibitors
12/04/2014US20140357681 Composition for Hot-Melt Extrusion and Method for Producing Hot-Melt Extrusion Product Using Same
12/04/2014US20140357676 Pharmaceutical compositions and methods for treating cancer and biomarkers for drug screening
12/04/2014US20140357670 Dihydropyridinone mgat2 inhibitors
12/04/2014US20140357669 Tazarotene derivatives
12/04/2014US20140357668 Treatment of cerebral palsy impaired speech in children
12/04/2014US20140357667 Treatment of cerebral palsy impaired speech in children
12/04/2014US20140357666 Compounds for inhibiting the interaction of bcl2 with binding partners
12/04/2014US20140357661 Chemical compounds
12/04/2014US20140357660 Gene expression signatures of neoplasm responsiveness to therapy
12/04/2014US20140357658 Opioid agonist/opioid antagonist/acetaminophen combinations
12/04/2014US20140357657 Pharmaceutical Formulation Containing Gelling Agent
12/04/2014US20140357656 Bivalent Ligands for the Treatment of Neurological Disorders
12/04/2014US20140357651 Combination pharmaceutical compositions and uses thereof
12/04/2014US20140357648 Therapeutic approaches for treating alzheimer's disease
12/04/2014US20140357645 Advanced Formulations and Therapies for Treating Hard-to-Heal Wounds
12/04/2014US20140357643 Derivatives of Betulin
12/04/2014US20140357642 IP receptor agonist heterocyclic compounds
12/04/2014US20140357641 IP receptor agonist heterocyclic compounds
12/04/2014US20140357639 Imidazole derivatives as PDE10 enzyme inhibitors
12/04/2014US20140357638 Compositions and methods for treating alzheimer's disease
12/04/2014US20140357637 Substituted annulated pyrimidines and triazines, and use thereof
12/04/2014US20140357636 Treatment of Skeletal-Related Disorders
12/04/2014US20140357634 Substituted 4-aminocyclohexane derivatives
12/04/2014US20140357633 Compounds for inhibiting the interaction of bcl2 with binding partners
12/04/2014US20140357632 Benzopiperazine derivatives as cetp inhibitors
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 7860